Rank #2805
Michelle Xia
Net worth $1.4B
Biotech · United States
- Born
- Nov 01, 1966
- Age
- 59
- Source
- Biotech
- Residence
- Zhongshan
- Citizenship
- United States
- Marital status
- Children
- 0
- Education
Net worth over time
Biography
- Michelle Yu Xia is cofounder, chairwoman and CEO of China-based biotech firm Akeso, which has multiple approved drugs in China to treat cancer.
- Akeso has captured attention in the biotech world because one of its drugs outperformed Merck's bestseller Keytruda in a head to head Phase 3 trial in 2024.
- The success of that Akeso drug, ivonescimab, drove up the price of Akeso's shares; the company is listed on the Hong Kong Stock Exchange.
- Prior to Akeso, Xia worked in research and at U.S. biotech firms for a dozen years starting in the mid 1990s and obtained U.S. citizenship while in America.
- Akeso licensed its most promising cancer drug to Miami-based firm Summit Therapeutics in 2022 for markets including the U.S., Europe and Japan.
Financial assets
| Exchange | Ticker | Shares | Price |
|---|